Vimarsana
Biggest News Aggregation in the World

Page 2 - Nasdaq Gh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Gh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Gh Today - Breaking & Trending Today

Guggenheim Reaffirms Neutral Rating for Guardant Health (NASDAQ:GH) - Vimarsana News

Guggenheim Reaffirms Neutral Rating for Guardant Health (NASDAQ:GH)

Guardant Health (NASDAQ:GH – Get Free Report)‘s stock had its “neutral” rating reiterated by investment analysts at Guggenheim in a research report issued on Friday, Benzinga reports. Several other equities research analysts have also recently issued reports on the stock. Wolfe Research initiated coverage on shares of Guardant Health in a research report on Wednesday, […]

China Universal Asset Management Co. Ltd. Boosts Stake in Guardant Health, Inc. (NASDAQ:GH) - Vimarsana News

China Universal Asset Management Co. Ltd. Boosts Stake in Guardant Health, Inc. (NASDAQ:GH)

China Universal Asset Management Co. Ltd. raised its position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 208.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,652 shares of the company’s stock after acquiring an additional […]

Guardant Health (NASDAQ:GH) Shares Up 3.9% - Vimarsana News

Guardant Health (NASDAQ:GH) Shares Up 3.9%

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) shares shot up 3.9% during mid-day trading on Thursday . The company traded as high as $18.82 and last traded at $18.66. 453,331 shares traded hands during mid-day trading, a decline of 73% from the average session volume of 1,687,167 shares. The stock had previously closed at […]

Source: wkrb13.com
Guardant Health (NASDAQ:GH) Price Target Lowered to $45.00 at JPMorgan Chase & Co. - Vimarsana News

Guardant Health (NASDAQ:GH) Price Target Lowered to $45.00 at JPMorgan Chase & Co.

Guardant Health (NASDAQ:GH – Free Report) had its target price lowered by JPMorgan Chase & Co. from $60.00 to $45.00 in a research note published on Friday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. A number of other equities analysts have also recently commented on GH. Guggenheim […]

Analysts Set Guardant Health, Inc. (NASDAQ:GH) Target Price at $46.75 - Vimarsana News

Analysts Set Guardant Health, Inc. (NASDAQ:GH) Target Price at $46.75

Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve analysts that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average […]